STOCK TITAN

Interim CFO appointed at Sharps Technology (NASDAQ: STSS)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Sharps Technology, Inc. appointed Arthur Levine as interim Chief Financial Officer under a fee agreement with DLA, LLC. His initial term is three months starting February 17, 2026, with any extension at the company’s discretion, and DLA will be paid $450 per hour for his services.

Levine is an experienced financial executive who has held CFO roles at public companies in healthcare and energy-related services and is a Certified Public Accountant. He has also signed the company’s standard indemnification agreement. Executive Chairman Paul Danner will serve as Principal Financial Officer while the company conducts its search for a permanent CFO.

Positive

  • None.

Negative

  • None.
false 0001737995 0001737995 2026-02-17 2026-02-17 0001737995 STSS:CommonStockParValue0.0001Member 2026-02-17 2026-02-17 0001737995 STSS:CommonStockPurchaseWarrantsMember 2026-02-17 2026-02-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): February 17, 2026

 

SHARPS TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-41355   82-3751728

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

105 Maxess Road, Suite 124,

Melville, NY 11747

(Address of principal executive office) (Zip Code)

 

(631) 574-4436

(Registrants’ telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001   STSS   Nasdaq Capital Market
Common Stock Purchase Warrants   STSSW   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

 

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01. Entry Into a Material Definitive Agreement.

 

The information set forth in Items 5.02 is incorporated by reference in this Item 1.01.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On February 13, 2026 Sharps Technology, Inc. (the “Company”) entered into a fee agreement with DLA, LLC (“DLA”), pursuant to which the Company appointed Arthur Levine as interim Chief Financial Officer of the Company for an initial term of three months, effective February 17, 2026, which may be extended at the sole discretion of the Company. The Company shall pay $450 per hour to DLA for Mr. Levine’s services.

 

Mr. Levine, age 68, has provided fractional and interim consulting services from 2023 to 2026 to companies in various industries at various stages of growth. From March 2021 to July 2023, Mr. Levine served as the Chief Financial Officer of NextNRG, Inc (f.k.a EzFill Holdings) (NASDAQ: NXXT) a mobile fueling company. From 2014 to 2020, Mr. Levine served as the Chief Financial Officer of Sensus Healthcare (NASDAQ: SRTS), a medical device company. Mr. Levine received his Bachelor of Science degree from The Wharton School of the University of Pennsylvania and is a Certified Public Accountant.

 

In accordance with the Company’s customary practice, on February 21, 2026 the Company entered into its standard form of indemnification agreement, effective February 17, 2026, with Mr. Levine, which requires the Company to indemnify Mr. Levine against certain liabilities that may arise as result of his status or service as the interim Chief Financial Officer.

 

There are no arrangements or understandings between the Company and Mr. Levine pursuant to which Mr. Levine was appointed and there is no family relationship between or among any director or executive officer of the Company or Mr. Levine. There are no transactions, to which the Company is or was a participant and in which Mr. Levine has a material interest subject to disclosure under Item 404(a) of Regulation S-K.

 

Paul Danner, Executive Chairman and Principal Executive Officer, will serve as the Company’s Principal Financial Officer. The Company has initiated its search for a Chief Financial Officer. The Company expects to retain the services of Mr. Levine until such time its search for a permanent replacement Chief Financial Officer is successfully concluded.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Sharps Technology, Inc.
     
Dated: February 23, 2026 By: /s/ Paul K. Danner
  Name: Paul K. Danner
  Title: Principal Executive Officer

 

 

 

 

FAQ

What did Sharps Technology (STSS) disclose in this 8-K filing?

Sharps Technology disclosed the appointment of Arthur Levine as interim Chief Financial Officer for an initial three-month term. His services are provided through DLA, LLC at $450 per hour while the company searches for a permanent CFO.

Who is Arthur Levine, the new interim CFO of Sharps Technology (STSS)?

Arthur Levine is a seasoned finance executive and Certified Public Accountant who previously served as CFO of NextNRG, Inc. and Sensus Healthcare. He has recently provided fractional and interim CFO consulting services to companies at various growth stages.

What are the key terms of Arthur Levine’s agreement with Sharps Technology (STSS)?

Sharps Technology engaged DLA, LLC to provide Arthur Levine as interim CFO for three months from February 17, 2026. The company will pay DLA $450 per hour for his services and has executed its standard indemnification agreement with him.

Who will act as Principal Financial Officer at Sharps Technology (STSS)?

Executive Chairman and Principal Executive Officer Paul Danner will also serve as Principal Financial Officer. He assumes this designation while Arthur Levine acts as interim Chief Financial Officer and the company continues its search for a permanent CFO.

Does Arthur Levine have any related-party transactions with Sharps Technology (STSS)?

The company states there are no transactions in which Sharps Technology is or was a participant and in which Arthur Levine has a material interest requiring disclosure under Item 404(a) of Regulation S-K. No family relationships with current directors or officers are disclosed.

How long does Sharps Technology (STSS) expect to retain interim CFO Arthur Levine?

Sharps Technology initially engaged Arthur Levine for a three-month term starting February 17, 2026. The company expects to retain his services until its search for a permanent Chief Financial Officer is successfully completed, with any extension at the company’s discretion.

Filing Exhibits & Attachments

4 documents
Sharps Tech

NASDAQ:STSS

STSS Rankings

STSS Latest News

STSS Latest SEC Filings

STSS Stock Data

55.67M
27.07M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MELVILLE